160 related articles for article (PubMed ID: 9820189)
21. Estrogen metabolism as a risk factor for head and neck cancer.
Yoo HJ; Sepkovic DW; Bradlow HL; Yu GP; Sirilian HV; Schantz SP
Otolaryngol Head Neck Surg; 2001 Mar; 124(3):241-7. PubMed ID: 11240983
[TBL] [Abstract][Full Text] [Related]
22. Estrogen metabolism and breast cancer.
Kabat GC; O'Leary ES; Gammon MD; Sepkovic DW; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Bradlow HL
Epidemiology; 2006 Jan; 17(1):80-8. PubMed ID: 16357599
[TBL] [Abstract][Full Text] [Related]
23. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
[TBL] [Abstract][Full Text] [Related]
24. Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial.
Campbell KL; Westerlind KC; Harber VJ; Bell GJ; Mackey JR; Courneya KS
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):731-9. PubMed ID: 17416764
[TBL] [Abstract][Full Text] [Related]
25. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial.
Mackey RH; Fanelli TJ; Modugno F; Cauley JA; McTigue KM; Brooks MM; Chlebowski RT; Manson JE; Klug TL; Kip KE; Curb JD; Kuller LH
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2022-32. PubMed ID: 22933427
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense
Green T; See J; Schauch M; Reil J; Glover M; Brix J; Gerry A; Li K; Newman M; Gahler RJ; Wood S
J Complement Integr Med; 2023 Mar; 20(1):199-206. PubMed ID: 36201753
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of urinary oestrogen excretion and breast cancer risk.
Key TJ; Wang DY; Brown JB; Hermon C; Allen DS; Moore JW; Bulbrook RD; Fentiman IS; Pike MC
Br J Cancer; 1996 Jun; 73(12):1615-9. PubMed ID: 8664140
[TBL] [Abstract][Full Text] [Related]
28. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2-hydroxyestrone ratio in C3H/HeJ mice.
Kishida T; Beppu M; Nashiki K; Izumi T; Ebihara K
Nutr Cancer; 2000; 38(2):209-14. PubMed ID: 11525599
[TBL] [Abstract][Full Text] [Related]
29. Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey.
Wang DY; Allen DS; De Stavola BL; Fentiman IS; Brussen J; Bulbrook RD; Thomas BS; Hayward JL; Reed MJ
Br J Cancer; 2000 May; 82(9):1577-84. PubMed ID: 10789728
[TBL] [Abstract][Full Text] [Related]
30. Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.
Sowers M; McConnell D; Jannausch ML; Randolph JF; Brook R; Gold EB; Crawford S; Lasley B
Clin Endocrinol (Oxf); 2008 May; 68(5):806-13. PubMed ID: 17980014
[TBL] [Abstract][Full Text] [Related]
31. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
Modugno F; Kip KE; Cochrane B; Kuller L; Klug TL; Rohan TE; Chlebowski RT; Lasser N; Stefanick ML
Int J Cancer; 2006 Mar; 118(5):1292-301. PubMed ID: 16161054
[TBL] [Abstract][Full Text] [Related]
32. Effect of energy deficiency on estrogen metabolism in premenopausal women.
Westerlind KC; Williams NI
Med Sci Sports Exerc; 2007 Jul; 39(7):1090-7. PubMed ID: 17596776
[TBL] [Abstract][Full Text] [Related]
33. Urinary estrogen metabolites and breast cancer: a case-control study.
Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
[TBL] [Abstract][Full Text] [Related]
34. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer.
Dalessandri KM; Firestone GL; Fitch MD; Bradlow HL; Bjeldanes LF
Nutr Cancer; 2004; 50(2):161-7. PubMed ID: 15623462
[TBL] [Abstract][Full Text] [Related]
35. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
[TBL] [Abstract][Full Text] [Related]
36. Re: "A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer".
Bradlow HL; Kabat GC
Environ Health Perspect; 1998 Mar; 106(3):A126-7. PubMed ID: 10408943
[No Abstract] [Full Text] [Related]
37. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
38. Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women.
Sturgeon SR; Volpe SL; Puleo E; Bertone-Johnson ER; Heersink J; Sabelawski S; Wahala K; Bigelow C; Kurzer MS
Nutr Cancer; 2010; 62(2):175-80. PubMed ID: 20099191
[TBL] [Abstract][Full Text] [Related]
39. Urinary estrogen metabolites and their ratio among Asian American women.
Falk RT; Fears TR; Xu X; Hoover RN; Pike MC; Wu AH; Nomura AM; Kolonel LN; West DW; Sepkovic DW; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):221-6. PubMed ID: 15668498
[TBL] [Abstract][Full Text] [Related]
40. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women.
Smith AJ; Phipps WR; Thomas W; Schmitz KH; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):756-64. PubMed ID: 23652373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
